KRAS and pancreatic neoplasm: YAP, a mediator of the Hippo signaling pathway that has been shown to mediate resistance to inhibition of MAPK signaling and promote Kras oncogene independence in oncogenic pancreatic cancer,24, 25 was enriched in relapsed NRI AMLs.